Alkane Resources has two main assets in Central West New South Wales: the Tomingley gold mine, where recent exploration has increased the mine life by at least eight years, from FY23 to FY31, and its Boda prospect at Northern Molong, which is shaping up to be a tier 1 alkalic porphyry district.
More Alkane Resources content >Investment summary
Alkane exceeded guidance in FY21 by nearly 4% and production of 44koz in 9M22 is in line with budget (at an all-in sustaining cost (AISC) guidance range of A$1,500–1,650/oz). Exploration at San Antonio and Roswell has already led to an increase in Tomingley’s life from CY23 until CY31 at production levels up to 115koz pa and AISC down to A$1,350–1,450/oz. Subsequent exploration has also increased the Roswell resource by 37%.
Y/E Jun |
Revenue (A$m) |
EBITDA (A$m) |
PBT (A$m) |
EPS (fd) (c) |
P/E (x) |
P/CF (x) |
|---|---|---|---|---|---|---|
| 2020A | 72.5 | 29.4 | 20.6 | 2.48 | 26.2 | 12.6 |
| 2021A | 127.8 | 70.5 | 46.3 | 5.30 | 12.3 | 5.4 |
| 2022E | 136.4 | 52.3 | 27.8 | 3.24 | 20.1 | 7.4 |
| 2023E | 128.2 | 57.3 | 31.4 | 3.67 | 17.7 | 6.8 |
Industry outlook
Our most recent valuation of Alkane attributed 33c/share in value to Tomingley plus net cash. To this could then be added 1) 6c for the eventual development of the Roswell underground extension, 2) 16c given the then level of the gold price (US$1,818/oz), 3) 4c for residual resources, 4) 3c for ongoing exploration success, 5) 15c for Alkane’s investments in Calidus and Genesis (albeit it has now sold the majority of its Genesis stake), and 6) up to 79c for exploration at Boda (where Alkane is aiming to announce a maiden resource imminently).
Last updated on 01/07/2022Content on Alkane Resources
Sector |
|---|
|
Metals & mining
Access more Metals & mining content
|
Share price graph
Balance sheet |
|
|---|---|
| Forecast net debt (m) | N/A |
| Forecast gearing ratio (%) | N/A |
Price performance
% |
1m |
3m |
12m |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||
| *% relative to local index | |||||||||||||||
Key management |
|
|---|---|
| Ian Gandel | Chairman |
| Nic Earner | MD |
| Ian Chalmers | Technical director |